Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 2;29(5):834-836.
doi: 10.1093/ibd/izac173.

IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame

Cristina Bezzio  1 , Gionata Fiorino  2 , Davide G Ribaldone  3 , Alessandro Armuzzi  4   5 , Simone Saibeni  1 ; IG-IBD COVID-19 Study Group
Collaborators, Affiliations

IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame

Cristina Bezzio et al. Inflamm Bowel Dis. .
No abstract available

Plain language summary

This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares. In the severe acute respiratory syndrome coronavirus 2 pandemic era, inflammatory bowel disease course is not influenced by infection, while therapy discontinuation is a risk factor for disease flare.

PubMed Disclaimer

References

    1. Stallmach A, Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis. 2002;8:213-218. - PubMed
    1. Craviotto V, Furfaro F, Loy L, et al. Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World J Gastroenterol. 2021;27:4276-4297. - PMC - PubMed
    1. Rahier JF, Yazdanpanah Y, Viget N, et al. Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2010;31:5-10. - PubMed
    1. Khan N, Patel D, Xie D, et al. Adherence of infusible biologics during the time of COVID-19 among patients with inflammatory bowel disease: a nationwide Veterans Affairs cohort study. Gastroenterology 2020;159:1592-1594. - PMC - PubMed
    1. Tripathi K, Godoy Brewer G, Thu Nguyen M, et al. COVID-19 and outcomes in patients with Inflammatory bowel disease: systematic review and meta-analysis. Inflamm Bowel Dis. Published online October 27, 2021. doi:10.1093/ibd/izab236 - DOI - PMC - PubMed